{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:41:21Z","timestamp":1784335281225,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,25]]},"DOI":"10.7759\/cureus.17446","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T22:38:06Z","timestamp":1629931086000},"source":"Crossref","is-referenced-by-count":3,"title":["Spinal Tuberculosis Secondary to Intravesical Bacille Calmette-Guerin Treatment for Bladder Cancer"],"prefix":"10.7759","author":[{"given":"Celeste G","family":"Yergin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Pafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Pirris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gazanfar","family":"Rahmathulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Intravesical therapy for non-muscle invasive bladder cancer\u2014current and future options in the age of bacillus Calmette-Guerin shortage","volume":"21","author":"Golla V","year":"2019","unstructured":"Golla V, Lenis AT, Faiena I, Chamie K. Intravesical therapy for non-muscle invasive bladder cancer\u2014current and future options in the age of bacillus Calmette-Guerin shortage. Rev Urol. 2019, 21:145-53.","journal-title":"Rev Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis AT","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder cancer: a review. JAMA. 2020, 324:1980-91. 10.1001\/jama.2020.17598","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2019.905","article-title":"The use of intravesical BCG in urothelial carcinoma of the bladder","volume":"13","author":"Alhunaidi O","year":"2019","unstructured":"Alhunaidi O, Zlotta AR. The use of intravesical BCG in urothelial carcinoma of the bladder. Ecancermedicalscience. 2019, 13:905. 10.3332\/ecancer.2019.905","journal-title":"Ecancermedicalscience"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)58737-6","article-title":"Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales A","year":"1976","unstructured":"Morales A, Eidinger D, Bruce AW. Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol. 1976, 116:180-2. 10.1016\/s0022-5347(17)58737-6","journal-title":"J Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(92)90439-4","article-title":"Mycobacterium bovis vertebral osteomyelitis and psoas abscess after intravesical BCG therapy for bladder carcinoma","volume":"40","author":"Katz DS","year":"1992","unstructured":"Katz DS, Wogalter H, D\u2019esposito RF, Cunha BA. Mycobacterium bovis vertebral osteomyelitis and psoas abscess after intravesical BCG therapy for bladder carcinoma. Urology. 1992, 40:63-6. 10.1016\/0090-4295(92)90439-4","journal-title":"Urology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2013.05.017","article-title":"Post-intravesical BCG epididymo-orchitis: case report and a review of the literature","volume":"4","author":"Parker SG","year":"2013","unstructured":"Parker SG, Kommu SS. Post-intravesical BCG epididymo-orchitis: case report and a review of the literature. Int J Surg Case Rep. 2013, 4:768-70. 10.1016\/j.ijscr.2013.05.017","journal-title":"Int J Surg Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5455\/medarh.2020.74.146-150","article-title":"Renal tuberculosis following intravesical bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy for the treatment of Bbadder cancer","volume":"74","author":"Bajramovic S","year":"2020","unstructured":"Bajramovic S, Alic J, Skopljak E, Chikha A, Vesnic S, Smajilbegovic V, Aganovic D. Renal tuberculosis following intravesical bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy for the treatment of Bbadder cancer. Med Arch. 2020, 74:146-50. 10.5455\/medarh.2020.74.146-150","journal-title":"Med Arch"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12178-018-9523-y","article-title":"Evaluation and management of pyogenic and tubercular spine infections","volume":"11","author":"Boody BS","year":"2018","unstructured":"Boody BS, Tarazona DA, Vaccaro AR. Evaluation and management of pyogenic and tubercular spine infections. Curr Rev Musculoskelet Med. 2018, 11:643-52. 10.1007\/s12178-018-9523-y","journal-title":"Curr Rev Musculoskelet Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.18-2-150","article-title":"Bone and joint infection","volume":"18","author":"Colston J","year":"2018","unstructured":"Colston J, Atkins B. Bone and joint infection. Clin Med (Lond). 2018, 18:150-4. 10.7861\/clinmedicine.18-2-150","journal-title":"Clin Med (Lond)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOS-D-13-00102","article-title":"Bacterial spine infections in adults: evaluation and management","volume":"24","author":"Cornett CA","year":"2016","unstructured":"Cornett CA, Vincent SA, Crow J, Hewlett A. Bacterial spine infections in adults: evaluation and management. J Am Acad Orthop Surg. 2016, 24:11-8. 10.5435\/JAAOS-D-13-00102","journal-title":"J Am Acad Orthop Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/BSD.0000000000000597","article-title":"The epidemiology of vertebral osteomyelitis in the United States from 1998 to 2013","volume":"31","author":"Issa K","year":"2018","unstructured":"Issa K, Diebo BG, Faloon M, Naziri Q, Pourtaheri S, Paulino CB, Emami A. The epidemiology of vertebral osteomyelitis in the United States from 1998 to 2013. Clin Spine Surg. 2018, 31:E102-8. 10.1097\/BSD.0000000000000597","journal-title":"Clin Spine Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2014.02.2573","article-title":"Defining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancer","volume":"192","author":"Kamat AM","year":"2014","unstructured":"Kamat AM, Witjes JA, Brausi M, et al.. Defining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancer. J Urol. 2014, 192:305-15. 10.1016\/j.juro.2014.02.2573","journal-title":"J Urol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-51889-0","article-title":"BCG instillation versus radical cystectomy for high-risk NMIBC with squamous\/glandular histologic variants","volume":"9","author":"Suh J","year":"2019","unstructured":"Suh J, Moon KC, Jung JH, et al.. BCG instillation versus radical cystectomy for high-risk NMIBC with squamous\/glandular histologic variants. Sci Rep. 2019, 9:15268. 10.1038\/s41598-019-51889-0","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)45091-9","article-title":"Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder","volume":"136","author":"Haaff EO","year":"1986","unstructured":"Haaff EO, Dresner SM, Ratliff TL, Catalona WJ. Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder. J Urol. 1986, 136:820-3. 10.1016\/s0022-5347(17)45091-9","journal-title":"J Urol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3233\/BLC-150015","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) treatment failures in non-muscle invasive bladder cancer: what truly constitutes unresponsive disease","volume":"1","author":"Steinberg RL","year":"2015","unstructured":"Steinberg RL, Thomas LJ, O'Donnell MA. Bacillus Calmette-Gu\u00e9rin (BCG) treatment failures in non-muscle invasive bladder cancer: what truly constitutes unresponsive disease. Bladder Cancer. 2015, 1:105-16. 10.3233\/BLC-150015","journal-title":"Bladder Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09891.x","article-title":"Maintenance therapy with bacillus Calmette-Gu\u00e9rin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer","volume":"108","author":"Hinotsu S","year":"2011","unstructured":"Hinotsu S, Akaza H, Naito S, et al.. Maintenance therapy with bacillus Calmette-Gu\u00e9rin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer. BJU Int. 2011, 108:187-95. 10.1111\/j.1464-410X.2010.09891.x","journal-title":"BJU Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000034450.80198.1c","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester RJ","year":"2002","unstructured":"Sylvester RJ, van der MEIJDEN AP, Lamm DL. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol. 2002, 168:1964-70. 10.1097\/01.ju.0000034450.80198.1c","journal-title":"J Urol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.02.040","article-title":"Maintenance therapy with 3-monthly bacillus Calmette-Gu\u00e9rin for 3 years is not superior to standard induction therapy in high-risk non-muscle-invasive urothelial bladder carcinoma: final results of randomised CUETO Study 98013","volume":"68","author":"Mart\u00ednez-Pi\u00f1eiro L","year":"2015","unstructured":"Mart\u00ednez-Pi\u00f1eiro L, Portillo JA, Fern\u00e1ndez JM, et al.. Maintenance therapy with 3-monthly bacillus Calmette-Gu\u00e9rin for 3 years is not superior to standard induction therapy in high-risk non-muscle-invasive urothelial bladder carcinoma: final results of randomised CUETO Study 98013. Eur Urol. 2015, 68:256-62. 10.1016\/j.eururo.2015.02.040","journal-title":"Eur Urol"},{"key":"ref19","unstructured":"UpToDate. Patient education: bladder cancer treatment; non-muscle invasive (superficial) cancer (beyond the basics). (2020). Accessed: May 28, 2021: https:\/\/www.uptodate.com\/contents\/bladder-cancer-treatment-non-muscle-invasive-superficial-cancer-beyond-the-basics."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2003.04764.x","article-title":"Bacillus Calmette-Gu\u00e9rin therapy in stage Ta\/T1 bladder cancer: prognostic factors for time to recurrence and progression","volume":"93","author":"Andius P","year":"2004","unstructured":"Andius P, Holm\u00e4ng S. Bacillus Calmette-Gu\u00e9rin therapy in stage Ta\/T1 bladder cancer: prognostic factors for time to recurrence and progression. BJU Int. 2004, 93:980-4. 10.1111\/j.1464-410X.2003.04764.x","journal-title":"BJU Int"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4103\/0970-1591.166445","article-title":"Non-muscle invasive bladder cancer risk stratification","volume":"31","author":"Isharwal S","year":"2015","unstructured":"Isharwal S, Konety B. Non-muscle invasive bladder cancer risk stratification. Indian J Urol. 2015, 31:289-96. 10.4103\/0970-1591.166445","journal-title":"Indian J Urol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2019180014","article-title":"Complications of intravesical BCG immunotherapy for bladder cancer","volume":"39","author":"Green DB","year":"2019","unstructured":"Green DB, Kawashima A, Menias CO, et al.. Complications of intravesical BCG immunotherapy for bladder cancer. Radiographics. 2019, 39:80-94. 10.1148\/rg.2019180014","journal-title":"Radiographics"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.10.029","article-title":"Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Gu\u00e9rin","volume":"62","author":"Palou J","year":"2012","unstructured":"Palou J, Sylvester RJ, Faba OR, Parada R, Pe\u00f1a JA, Algaba F, Villavicencio H. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Gu\u00e9rin. Eur Urol. 2012, 62:118-25. 10.1016\/j.eururo.2011.10.029","journal-title":"Eur Urol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/67116-spinal-tuberculosis-secondary-to-intravesical-bacille-calmette-guerin-treatment-for-bladder-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:29:47Z","timestamp":1707506987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/67116-spinal-tuberculosis-secondary-to-intravesical-bacille-calmette-guerin-treatment-for-bladder-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,25]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.17446","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,25]]}}}